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Abstract 
We have investigated the pattern of PTPase transcript expression during in vitro differentiation fmouse mbryonal carcinoma (F9) cells. While 
the transcripts of most PTPases were unchanged or undetected during embryonal differentiation i duced by retinoic acid, several PTPase transcripts 
exhibited istinct patterns of induction. Mutant cells defective in differentiation did not display the induction of some of these PTPase transcripts. 
Interestingly, three out of the four PTPase transcripts induced were the same PTPase transcripts induced during in vitro erythroid ifferentiation 
of mouse erythrolenkemia (MEL) cells [(1982) Biochem. Biophys. Res. Commun. 107, 1104-1109]. The possible role played by specific PTPases in 
cell differentiation is discussed. 
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1. Introduction 
F9, an established mouse embryonal carcinoma cell
line, differentiates into primitive endoderm-like c lls in 
vitro when treated with retinoic acid [1]. Dibutyryl cyclic 
AMP (dbcAMP) treatment further differentiates the 
primitive endoderm-like c lls into those which exhibit 
characteristics of parietal endoderm cells [2,3]. The endo- 
derm-like cells can also be converted to visceral endo- 
derm-like cells when exposed to cell-aggregation condi- 
tions [3]. Because of these distinct characteristics of dif- 
ferentiation, F9 cells have been widely used as a model 
for studying the mechanism of embryonic differentia- 
tion. 
We have shown previously that inhibitors of protein 
tyrosine kinases, such as herbimycin A, induce F9 differ- 
entiation like retinoic acid [4], suggesting that the 
dephosphorylation of phosphorylated tyrosine moieties 
of cellular proteins is involved in the differentiation proc- 
ess. Possible involvement of tyrosine dephosphorylation 
has been studied more extensively inerythroid ifferenti- 
ation of mouse erythroleukemia (MEL) cells, in which 
not only a series of inhibitors of protein tyrosine kinases 
induce differentiation, but also phosphotyrosine moie- 
ties of cellular proteins were rapidly dephosphorylated 
at a very early stage of differentiation [4-9]. Na3VO4, a 
specific inhibitor of protein tyrosine phosphatases 
(PTPases) [10], has been shown to prevent tyrosine 
dephosphorylation as well as erythroid ifferentiation 
[8]. More recently, we have found that the quantitative 
*Corresponding author. Fax: (81) (3) 3818 9437. 
level of transcripts for three specific PTPases is sharply 
increased at a very early stage of differentiation [11]. 
In order to explore the possible involvement ofprotein 
tyrosine dephosphorylation n differentiation, we exam- 
ined the level of transcripts of sixteen known and re- 
cently cloned PTPases during F9 cell differentiation. 
Here we report that while the transcripts of most of the 
PTPases were unchanged or undetected, several specific 
PTPase transcripts were induced during embryonal dif- 
ferentiation i duced by retinoic acid. Mutant F9 cells 
defective in differentiation did not show the induction of 
some of the PTPase transcripts. Comparing the patterns 
of expression of these PTPase transcripts during F9 cell 
differentiation with those during erythroid ifferentia- 
tion of MEL cells, the possible roles of PTPases in cell 
differentiation is discussed. 
2. Materials and methods 
2.1. Materials 
Retinoic acid (RA) and dibutyryl cyclic AMP (dbcAMP) were pur- 
chased from Sigma. ES medium was purchased from Nissui Seiyaku 
(Tokyo). Fetal calf serum (FCS) was obtained from United Biotech. 
[~t-32p]dCTP was purchased from ICN. All other agents were reagent 
grade. 
2.2. Cells and cell culture 
F9 cells were supplied by Dr. Y. Nishimune. Differentiation-defec- 
tive mutant cell lines (RAt-6 and ROT r. 1 ) were isolated from N-methyl- 
N'-nitro-N-nitrosoguanidine-treated F9 c lls. The cells were cultured at 
37°C in a CO2 (5%) incubator in ES medium supplemented with FCS 
(10%). Plastic tissue culture dishes had been coated with gelatin solution 
(0.4%) before use. 
2.3. Assay for plasminogen activator (PA) 
Plasminogen activator was assayed as described by Nishimune t al. 
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[12]. In essence, F9 cells were overlaid with ES medium containing 
Noble agar (0.75%, w/v), skimmed milk (2.5%, w/v), and human plas- 
minogen (0.2 casein U/ml). After 24 h of incubation at 37"C in a CO2 
incubator, haloes were counted. In a standard assay, over 200 colonies 
per plate (in duplicate) were examined. 
2.4. Northern blot analysis 
Exponentially grown F9 cells were exposed to retinoic acid (1 ltM) 
or reteinoic acid (1 pM) plus dbcAMP (1 raM). At different ime 
intervals the cells (~2 x l0 s cells) were collected by a rubber policeman, 
washed with cold PBX (3 times), lysed in 2.4 ml of RNA extraction 
buffer (140 mM NaCI, 1.5 mM MgCI2, 10 mM Tris-HCl, pH 8.6, and 
0.5% Nonidet P40) and total RNA was prepared as described [13]. 
Poly(A) + RNA was obtained from the total RNA preparations using 
Oligotex-dT30 (Takara Shuzo) according to the manufacturer's in- 
struction. 
For Northern blotting, poly(A) + RNA was electrophoresed on a 1% 
formaldehyde-agarose gel, blotted onto a Hybond N ÷ membrane 
(Amersham), and hybridized with 32p-labeled PTPase cDNA probes 
which were prepared by random priming (Boehringer-Mannheim) 
using [~-32p]dCTP. The specific activities of the probes were approxi- 
mately 2 × 109 cpm]/~g DNA. The hybridization was carried out over- 
night at 420C in a hybridization buffer (50% fomamide, 5 × SSC, 50 
mM Tris-HC1, pH 7.5, 0.1% SDS and 0.1 mg/ml sonicated herring 
sperm DNA). The membranes were washed once with 2 × SSC, 0.1% 
SDS for 10 min at room temperature, once with 2 × SSC, 0.1% SDS for 
15 rain at 65*C, twice with 0.1 × SSC, 0.1% SDS for 15 rain at 65°C 
and autoradiographed using Kodak X-OMAT films (exposure for 
overnight). 
3. Results and discussion 
We first examined whether the transcription of any 
specific PTPase transcripts was induced or the quantita- 
tive level of transcripts was altered uring F9 cell differ- 
entiation. The cells were incubated in the presence of 
retinoic acid (for primitive ndoderm differentiation) or 
retionic acid plus dbeAMP (for parietal endoderm differ- 
entiation). Poly (A) + RNAs were prepared from the cells 
at different time intervals up to 96 h. Under the condi- 
tions employed, both primitive and parietal endoderm 
differentiation were completed by approximately 72 h of 
incubation, and the cellular commitment to differentia- 
Table 1 
List of PTPase clones 
Clone Reference 
CDC25C Sadhu et al. [14] 
Cdc25M2 Kakizuka et al. [15] 
CD45 Thomas et al. [16] 
LRP Mattbews et al. [17] 
MPTP Mosinger et al. [18] 
PEP Matthews et al. [19] 
PTPfl2 (BET) Thomas et al. [20] 
PTPJ Thomas et al. [20] 
PTPe Thomas et al. [20] 
PTPr (MBR) Thomas et al. [20] 
PTP/~ Gebbink et al. [21] 
PTP-S Swamp et al. [22] 
RIP (MTC) Thomas et al. [20] 
SHP Matthews et al. [19] 
SH-PTP2 Freeman et al. [23] 
STEP Lombroso et al. [24] 
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Fig. 1. Alteration of PTPase transcripts during F9 cell differentiation. 
Exponentially grown F9 ceils were exposed to retinoic acid (1/~M) or 
retinoic acid (1/tM) plus dbcAMP (1 raM). Cells (-2 × 108) were col- 
lected at 0, 24, 48, 72 and 96 h of incubation with the agents, and 
poly(A) + RNA was prepared. The RNA (2/lg) was then subjected to 
Northern blot analysis using various 32p-labeled PTPase and control 
(pyruvate kinase) eDNA probes. 
tion is thought o occur much earlier, by 24-48 h of 
incubation. The RNAs were then subjected to Northern 
blot analysis using PTPase probes. For the probes, we 
used sixteen different mammalian PTPase eDNA clones 
which included many of the recently cloned PTPase 
eDNAs. The eDNA clones used as probes are listed in 
Table 1. 
Transcripts of thirteen PTPases out of the sixteen ex- 
amined were detected in control (untreated) cells or in- 
duced cells or both. In Fig. 1, we show the patterns of 
expression of seven PTPase transcripts, representatives 
of the PTPase transcripts detected up to 96 h after the 
addition of retinoie acid or retinoic acid plus dbcAMP. 
They were roughly classified into several groups accord- 
ing to their pattern of altered expression during differen- 
tiation. Some of the PTPase transcripts, exemplified by 
MPTP in the figure, remained at relatively constant lev- 
els up to 72 h after treatment of the cells with retinoic 
acid as well as retinoie acid plus dbcAMP. The other 
transcripts which behaved similarly to MPTP transcripts 
included those for CDC25C, Cdc25M2, PTP~¢ (MBR), 
PTP-S, SH-PTP2 and STEP (data not shown). In the 
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96 h samples the quantitative level of these PTPase tran- 
scripts and most of the others were found to be signifi- 
cantly lower, probably as a result of prolonged incuba- 
tion of differentiated cells. 
In contrast to these PTPase transcripts which re- 
mained unchanged during F9 differentiation, six PTPase 
transcripts exhibited alteration in their levels of expres- 
sion (Fig. 1). Among them, the level of SHP transcripts 
gradually decreased, particularly in the cells treated with 
retinoic acid plus dbcAMP. LRP transcripts were pres- 
ent at a significantly high level in control cells and the 
level increased gradually (2-3 fold) during differentia- 
tion. In contrast to these PTPase transcripts, four 
PTPase transcripts (PTPfl2, RIP, PTPe, PTPg) either 
were not detected or existed at a very low level in the 
untreated cells, but their levels increased substantially 
starting at between 24 and 48 h incubation with retinoic 
acid or retinoic acid plus dbeAMP, suggesting that these 
PTPases are involved in F9 differentiation. 
The experiments shown in Fig. 1 also indicate that no 
significant differences, with the possible exception of 
SHP transcripts, were observed between the patterns of 
expression of the PTPase transcripts in the cells treated 
with retinoic acid and those treated with retinoic acid 
plus dbcAMP. We also examined the patterns of expres- 
sion of the PTPase transcripts during F9 differentiation 
to visceral endoderm-like c lls when induced by aggrega- 
tion of the cells in the presence of retinoic acid. The 
results were essentially the same as those observed for 
cells treated with retinoic acid or retinoic acid plus 
dbcAMP (data not shown). Since differentiation topari- 
etal endoderm-like cells (induced by retinoic acid plus 
dbcAMP) and to visceral endoderm-like cells (induced 
by aggregation i  the presence of retinoic acid) is via 
primitive endoderm-like c lls (induced by retinoic acid), 
the results suggest that alteration of the patterns of ex- 
pression of specific PTPase transcripts reflects a cellular 
response to differentiation to primitive endoderm-like 
cells, and not to the subsequent differentiation toparietal 
or visceral endoderm-like cells. 
In order to obtain further evidence for the relationship 
between the increased quantitative l vel of the transcripts 
for PTPfl2, RIP, PTPe and PTPg and F9 differentiation, 
Table 2 
Plasminogen activator production n mutant F9 cells 
Cells Plasminogen activator-positive colonies 
(%) 
Retinoic acid 
Wild-type 0.3 77.1 
RAr-6 0.2 1.7 
ROTr-1 0.3 1.1 
Cells were incubated with or without retinoic acid (1/IM) for 2 days 
and plasminogen activator-positive colonies were assayed as described 
in section 2. 
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Fig. 2. Induction of MPTP, RIP, PTPe and PTP~ transcripts in differ- 
entiation-defective F9 cell mutants. Exponentially grown wild-type F9 
cells and differentiation-defective mutant cells RAt-6 and ROTr-1 were 
exposed to retinoic acid (1 gM). At 0, 48 and 96 h of incubation with 
retinoic acid, cells (~2 × 108) were collected and poly(A) + RNA was 
prepared. The RNA (3 gg) was then subjected to Northern blot analysis 
using 32p-labeled MPTP, RIP, PTPe, PTP~, and control (pyruvate 
kinase) cDNA probes. 
we examined the expression level of these FFPase tran- 
scripts (plus MPTP as a positive control) in differentia- 
tion-defective mutant F9 cells (RAr-6 and ROTr-1). 
These mutant F9 cells were independently isolated and 
are defective at least for both primitive endoderm and 
parietal endoderm differentiation [25]. The loss of plas- 
minogen activator production, an indication of primitive 
endoderm differentiation, of these mutant cells is shown 
in Table 2. The mutant cells were incubated in the pres- 
ence of retinoic acid, and poly(A) + RNAs isolated at 
different ime intervals were subjected to Northern blot 
analysis as performed earlier. The results are shown in 
Fig. 2. RIP and PTPe transcripts were hardly detected 
in either of these mutant cells before and after retinoic 
acid treatment. As for the PTPg transcripts, they were 
detected inthe mutant cells but the level of expression did 
not increase significantly as observed in the parental cells 
after retinoic acid treatment. The pattern of expression 
of PTPfl2 transcripts in the mutant cells did not differ 
significantly from that in the parental cells (data not 
shown). It seems that the transcription of at least three 
PTPases (PTPe, PTPg and RIP) was affected by the 
introduction of the mutation(s) which resulted in defec- 
tive F9 differentiation. These results further support he 
view that the induction of specific PTPase transcripts i  
associated with F9 differentiation, although it is not clear 
whether the behavior of these PTPase transcripts in the 
mutant cells is a direct result of the mutations or an 
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indirect consequence of the defect in differentiation of 
these mutant cells. 
We reported recently that three specific PTPase tran- 
scripts (RIP, PTPfl2 and PTPe) among over one dozen 
known and recently cloned PTPases were induced atan 
early stage of differentiation i  MEL cells induced by 
DMSO or HMBA [11]. In the experiments presented 
here, we found that four out of sixteen known PTPase 
transcripts were apparently induced during F9 differenti- 
ation. Among them, RIP, PTPfl2 and PTPe are the ones 
which also exhibited induction in MEL cell differentia- 
tion. The RIP transcripts were either non-detectable or 
remained at  very low level in mutant MEL cells defec- 
tive in erythroid ifferentiation [11]. Although the behav- 
ior of these transcripts must be carefully interpreted, the 
induction of these three specific PTPase transcripts (RIP, 
PTPfl2 and PTPe) during both MEL and F9 cell differen- 
tiation may not be simply coincidental. If this is the case, 
one could speculate that one (or more) of these specific 
PTPases plays a common role in the induction of differ- 
entiation in two entirely different in vitro differentiation 
systems, one of which is a terminal differentiation and 
another an embryonic differentiation. 
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